Dying Patients With Rare Diseases Struggle to Get Experimental Therapies
(By Christina Bennett for Kaiser Health News) At 15, Autumn Fuernisen is dying. She was diagnosed at age 11 with
Read More
Part D/Prescription Drugs
When Medicare issues come up, where do you go for help
So who do you turn to if you have any concerns about Medicare? Depending on your problem or question, there
Read MoreCMS pushed to set national policy on Aduhelm access
(By Nick Moran for Becker’s Hospital Review) The Alzheimer’s Association joins insurers as the latest to call for CMS to
Read MoreWhen and how will we know if we need Covid-19 booster shots?
(By the STAT Staff) There’s a lot we don’t yet know about the data behind Pfizer and BioNTech’s renewed push
Read MoreWhy the pharmaceutical industry has ‘mixed views’ on Biden’s latest executive order
(By Katie Adams for Becker’s Hospital Review) The American Pharmacists Association “has mixed views” on the executive order President Joe
Read MoreWhy We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
(By Elisabeth Rosenthal for Kaiser Health News) The Food and Drug Administration’s approval in June of a drug purporting to
Read MoreDrugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
(By Michael McAuliff for Kaiser Health News) The largest drug companies are far more interested in enriching themselves and investors
Read MoreHow to pick a Medigap plan that’s right for you
If you have about to turn age 65, you are receiving confusing literature on your Medicare choices. One choice you
Read MoreDelta Is Now The Dominant Coronavirus Variant In The U.S.
(By Jane Greenhalgh and Rob Stein for NPR) The highly contagious delta variant now accounts for more than 51% of
Read MoreJuly price hikes have been announced for 32 brand drugs
According to GoodRx, price hikes by pharmaceutical manufacturers are averaging 3.6 percent for the month of July. with the recent
Read More